Lymphoma Newsletter

Sep 11, 2018-edited

Stay Current With Lymphoma Treatment Advances & Connect with Others

CancerConnect publishes daily cancer news, original articles and "tips" on the management of lymphoma. These are available in our monthly lymphoma newsletter.

Stay Current - Connect With Other Lymphoma Patients

Join The CancerConnect Community: Connect with others and receive regular updates

Sign up for the Lymphoma Newsletter Here

Comments

Overview of Non Hodgkins Lymphoma

Understanding Lymphomas: Risks, Causes, Evaluation, Staging and Treatment Planning.

Cancer Connect

Mar 4

The Non Hodgkins Lymphoma Community - Connect With Other NHL Patients

Connect with Others at Top Cancer Centers - Second Opinion Options...

TraceyS

May 6

Lymphoma Classifications

Classification of Non-Hodgkin Lymphomas is necessary to determine treatment.

Cancer Connect

Sep 21, 2018

Rituxan Maintenance Therapy for Non Hodgkin Lymphoma

Rituxan maintenance in follicular & mantle cell lymphoma demonstrated to delay recurrence by more than 5 years.

Cancer Connect

Aug 4

Diagnosed with Lymphoma: 10 Tips on How to Get The Most From Your Doctor

Ten things every patient with lymphoma should consider in order to get the best possible treatment

MedMaven

May 31

A New Drug, Pentostatin, is Promising for Treatment of T-Cell Lymphomas

T-cell lymphomas frequently involve the skin and have a variable, but in general, poor outcome with current treatment.

Cancer Connect

Mar 8, 2009

High Dose Chemotherapy and Stem Cell Transplant for Highly Aggressive NHL

Overview of Autologous Stem Cell Transplant for treatment of Burkitts, small cleaved and highly aggressive NHL

Cancer Connect

Mar 6

Treanda-Rituxan-Polivy Represents new Treatment Option for Recurrent DLBCL

FDA Approves Chemoimmunotherapy Regimen for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

MedMaven

Jun 10

Jury Determines That Monsanto’s Roundup Responsible for Lymphoma - EPA Disagrees

Superior court jury decides NHL was at least partly caused by glyphosate, an ingredient in RoundUp. US EPA Disagrees

MedMaven

May 6

Umbralisib A Potential New Treatment for Marginal Zone Lymphoma

PI3K inhibitors are a promising new therapy for the management of b cell lymphomas and are being evaluated in MZL.

MedMaven

Jun 11

Cancer Connect

theRAconnection

The Spine Community

Osteoporosis

Women's Health

Lymphoma Newsletter

Stay Current - Connect With Other Lymphoma Patients

Cancer Connect

theRAconnection

The Spine Community

Osteoporosis

Women's Health

CancerConnect Lymphoma Newsletter

Stay Current - Connect With Other Lymphoma Patients